• Something wrong with this record ?

Skeletal Effects of Inducible ERα Deletion in Osteocytes in Adult Mice

ML. Doolittle, D. Saul, J. Kaur, JL. Rowsey, B. Eckhardt, S. Vos, S. Grain, K. Kroupova, M. Ruan, M. Weivoda, MJ. Oursler, JN. Farr, DG. Monroe, S. Khosla

. 2022 ; 37 (9) : 1750-1760. [pub] 20220722

Language English Country United States

Document type Journal Article, Research Support, N.I.H., Extramural

Grant support
P01 AG004875 NIA NIH HHS - United States
P01 AG062413 NIA NIH HHS - United States
R01 AG063707 NIA NIH HHS - United States
R01 DK128552 NIDDK NIH HHS - United States
R01 AR068275 NIAMS NIH HHS - United States

Estrogen is known to regulate bone metabolism in both women and men, but substantial gaps remain in our knowledge of estrogen and estrogen receptor alpha (ERα) regulation of adult bone metabolism. Studies using global ERα-knockout mice were confounded by high circulating sex-steroid levels, and osteocyte/osteoblast-specific ERα deletion may be confounded by ERα effects on growth versus the adult skeleton. Thus, we developed mice expressing the tamoxifen-inducible CreERT2 in osteocytes using the 8-kilobase (kb) Dmp1 promoter (Dmp1CreERT2 ). These mice were crossed with ERαfl//fl mice to create ERαΔOcy mice, permitting inducible osteocyte-specific ERα deletion in adulthood. After intermittent tamoxifen treatment of adult 4-month-old mice for 1 month, female, but not male, ERαΔOcy mice exhibited reduced spine bone volume fraction (BV/TV (-20.1%, p = 0.004) accompanied by decreased trabecular bone formation rate (-18.9%, p = 0.0496) and serum P1NP levels (-38.9%, p = 0.014). Periosteal (+65.6%, p = 0.004) and endocortical (+64.1%, p = 0.003) expansion were higher in ERαΔOcy mice compared to control (Dmp1CreERT2 ) mice at the tibial diaphysis, reflecting the known effects of estrogen to inhibit periosteal apposition and promote endocortical formation. Increases in Sost (2.1-fold, p = 0.001) messenger RNA (mRNA) levels were observed in trabecular bone at the spine in ERαΔOcy mice, consistent with previous reports that estrogen deficiency is associated with increased circulating sclerostin as well as bone SOST mRNA levels in humans. Further, the biological consequences of increased Sost expression were reflected in significant overall downregulation in panels of osteoblast and Wnt target genes in osteocyte-enriched bones from ERαΔOcy mice. These findings thus establish that osteocytic ERα is critical for estrogen action in female, but not male, adult bone metabolism. Moreover, the reduction in bone formation accompanied by increased Sost, decreased osteoblast, and decreased Wnt target gene expression in ERαΔOcy mice provides a direct link in vivo between ERα and Wnt signaling. © 2022 American Society for Bone and Mineral Research (ASBMR).

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024599
003      
CZ-PrNML
005      
20230912104445.0
007      
ta
008      
221017s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jbmr.4644 $2 doi
035    __
$a (PubMed)35789113
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Doolittle, Madison L $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA
245    10
$a Skeletal Effects of Inducible ERα Deletion in Osteocytes in Adult Mice / $c ML. Doolittle, D. Saul, J. Kaur, JL. Rowsey, B. Eckhardt, S. Vos, S. Grain, K. Kroupova, M. Ruan, M. Weivoda, MJ. Oursler, JN. Farr, DG. Monroe, S. Khosla
520    9_
$a Estrogen is known to regulate bone metabolism in both women and men, but substantial gaps remain in our knowledge of estrogen and estrogen receptor alpha (ERα) regulation of adult bone metabolism. Studies using global ERα-knockout mice were confounded by high circulating sex-steroid levels, and osteocyte/osteoblast-specific ERα deletion may be confounded by ERα effects on growth versus the adult skeleton. Thus, we developed mice expressing the tamoxifen-inducible CreERT2 in osteocytes using the 8-kilobase (kb) Dmp1 promoter (Dmp1CreERT2 ). These mice were crossed with ERαfl//fl mice to create ERαΔOcy mice, permitting inducible osteocyte-specific ERα deletion in adulthood. After intermittent tamoxifen treatment of adult 4-month-old mice for 1 month, female, but not male, ERαΔOcy mice exhibited reduced spine bone volume fraction (BV/TV (-20.1%, p = 0.004) accompanied by decreased trabecular bone formation rate (-18.9%, p = 0.0496) and serum P1NP levels (-38.9%, p = 0.014). Periosteal (+65.6%, p = 0.004) and endocortical (+64.1%, p = 0.003) expansion were higher in ERαΔOcy mice compared to control (Dmp1CreERT2 ) mice at the tibial diaphysis, reflecting the known effects of estrogen to inhibit periosteal apposition and promote endocortical formation. Increases in Sost (2.1-fold, p = 0.001) messenger RNA (mRNA) levels were observed in trabecular bone at the spine in ERαΔOcy mice, consistent with previous reports that estrogen deficiency is associated with increased circulating sclerostin as well as bone SOST mRNA levels in humans. Further, the biological consequences of increased Sost expression were reflected in significant overall downregulation in panels of osteoblast and Wnt target genes in osteocyte-enriched bones from ERαΔOcy mice. These findings thus establish that osteocytic ERα is critical for estrogen action in female, but not male, adult bone metabolism. Moreover, the reduction in bone formation accompanied by increased Sost, decreased osteoblast, and decreased Wnt target gene expression in ERαΔOcy mice provides a direct link in vivo between ERα and Wnt signaling. © 2022 American Society for Bone and Mineral Research (ASBMR).
650    _2
$a adaptorové proteiny signální transdukční $x metabolismus $7 D048868
650    _2
$a dospělí $7 D000328
650    _2
$a zvířata $7 D000818
650    12
$a alfa receptor estrogenů $x genetika $x metabolismus $7 D047628
650    _2
$a estrogeny $x metabolismus $x farmakologie $7 D004967
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a mezibuněčné signální peptidy a proteiny $x metabolismus $7 D036341
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši knockoutované $7 D018345
650    _2
$a osteoblasty $x metabolismus $7 D010006
650    12
$a osteocyty $x metabolismus $7 D010011
650    _2
$a messenger RNA $x metabolismus $7 D012333
650    _2
$a tamoxifen $x farmakologie $7 D013629
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Saul, Dominik $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA
700    1_
$a Kaur, Japneet $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA
700    1_
$a Rowsey, Jennifer L $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA
700    1_
$a Eckhardt, Brittany $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA
700    1_
$a Vos, Stephanie $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA
700    1_
$a Grain, Sarah $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA
700    1_
$a Kroupová, Květa $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA $u University Hospital Hradec Kralove and the Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic $7 xx0306762
700    1_
$a Ruan, Ming $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA
700    1_
$a Weivoda, Megan $u Robert and Arlene Kogod Center on Aging and Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USA
700    1_
$a Oursler, Merry Jo $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA
700    1_
$a Farr, Joshua N $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA $1 https://orcid.org/0000000231796414
700    1_
$a Monroe, David G $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA $1 https://orcid.org/0000000248180114
700    1_
$a Khosla, Sundeep $u Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA $1 https://orcid.org/0000000229364372
773    0_
$w MED00002559 $t Journal of bone and mineral research $x 1523-4681 $g Roč. 37, č. 9 (2022), s. 1750-1760
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35789113 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20230912104442 $b ABA008
999    __
$a ok $b bmc $g 1854365 $s 1175889
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 37 $c 9 $d 1750-1760 $e 20220722 $i 1523-4681 $m Journal of bone and mineral research $n J Bone Miner Res $x MED00002559
GRA    __
$a P01 AG004875 $p NIA NIH HHS $2 United States
GRA    __
$a P01 AG062413 $p NIA NIH HHS $2 United States
GRA    __
$a R01 AG063707 $p NIA NIH HHS $2 United States
GRA    __
$a R01 DK128552 $p NIDDK NIH HHS $2 United States
GRA    __
$a R01 AR068275 $p NIAMS NIH HHS $2 United States
LZP    __
$a Pubmed-20221017

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...